The intestinal mucosa is exposed to large amounts of foreign antigen (Ag) derived from commensal bacteria, dietary Ags, and intestinal pathogens. Dendritic cells (DCs) are believed to be involved in the induction of tolerance to harmless Ags and in mounting protective immune responses to pathogens and, as such, to play key roles in regulating intestinal immune homeostasis. The characterization of classical DCs (cDCs) in the intestinal lamina propria has been under intense investigation in recent years but the use of markers (including CD11c, CD11b, MHC class II), which are also expressed by intestinal M s, has led to some controversy regarding their definition. Here we review recent studies that help to distinguish cDCs subsets from monocyte-derived cells in the intestinal mucosa. We address the phenotype and ontogeny of these cDC subsets and highlight recent findings indicating that these subsets play distinct roles in the regulation of mucosal immune responses in vivo.
Introduction
Dendritic cells (DCs) are present throughout most tissues of the body where their main function is to sample self and foreign antigens (Ags), migrate to draining lymph nodes (LNs), and present antigenic peptides to naïve T cells, inducing their proliferation and differentiation. In so doing, DCs provide a critical link between the innate and adaptive immune systems. The intestinal lumen contains huge quantities of foreign Ag derived from commensal bacteria, dietary components, and occasional pathogenic microbes. Intestinal DCs are believed to play a central role in intestinal immune homeostasis, by inducing tolerance to harmless Ags, initiating protective immunity against intestinal pathogens, and conCorrespondence: Prof. William W. Agace e-mail: william.agace@med.lu.se tributing to intestinal diseases including celiac disease and the inflammatory bowel diseases (IBD, Crohn's disease, and ulcerative colitis).
Classical DCs (cDCs) are found throughout the intestinal lamina propria (LP), in gut-associated lymphoid tissue (GALT) including Peyer's patches (PPs) and isolated lymphoid follicles (ILFs), and in intestinal draining LNs such as the mesenteric LNs (MLNs). In the MLNs, cDCs can be broadly classified into lymphoid tissue resident cDCs, which are thought to derive from circulating precursors that enter directly from the blood, and migratory cDCs that arrive in organized lymphoid tissues via afferent lymph after acquiring Ag in the intestinal LP. While lymphoid tissue cDCs have been studied extensively, the + CD11b − cDCs, both of which are CX3CR1 lo/− . In addition there is a minor population of CD103 − cDCs that express variable levels of CD11b, the majority of which are CX3CR1 int . The CD11b − cells within this latter population are not present in intestinal preparations of RORγt −/− mice, which lack PPs and ILFs, suggesting they derive from GALT and not intestinal LP [5] .
functions of the intestinal cDCs that migrate to MLNs are less well understood.
The characterization of cDCs in the intestinal LP has been the subject of intense investigation and controversy, in part because the markers initially used to define them (including CD11c, CD11b and MHC class II (MHCII)) are also expressed by M s. In this review we discuss recent findings that have started to unravel the complexity of migratory intestinal cDCs, including assessment of the precursor-product relationships of transferred monocytes and cDC precursors, the identification of novel markers that appear to distinguish cDCs and monocytederived M s and new models that shed light on their in vivo functionality.
Defining cDC subsets in the intestinal mucosa
Although cDCs and other mononuclear phagocytes (MPs) such as monocytes and monocyte-derived M s in steady-state mouse LP can all express MHCII and CD11c, cDCs can be distinguished by their lack of expression of the high-affinity IgG receptor FcγR1, CD64 [1, 2] (Fig. 1) (Fig. 1 ). These subsets differ in their localization, transcription factor requirements, and function. Finally, there is a distinct population of CD11c + MHCII + CD103 − MPs in the intestine, which lack expression of the monocyte/M marker CD64 [4] , and express heterogeneous levels of CD11b (Fig. 1 ). As will be discussed below, several lines of evidence suggest that these cells are bona fide migratory cDCs. Notably, intestinal CD103 − CD11b − but not CD103 − CD11b + cDC numbers are significantly reduced in RORγt −/− mice that lack PPs and ILFs, suggesting that the former are GALT derived while the latter are resident within the intestinal LP [5] .
Ontogeny of intestinal cDC subsets

Intestinal cDC precursors
According to current models, cDCs derive from committed cDC progenitors that develop in the bone marrow (BM) and travel via the blood to lymphoid organs and nonlymphoid tissues, where they differentiate into mature cDCs [6] [7] [8] [9] . Adoptive transfer studies have demonstrated that pre-cDCs, but not monocytes, give rise to both CD103 + CD11b + and CD103 + CD11b − cDCs in the intestinal LP [10, 11] . In addition, a subset of lineage − CD11c + α4β7 + B220 + CCR9 − cells termed premucosal DC progenitors was recently identified, which appeared, upon adoptive transfer, to home preferentially to the intestinal mucosa and give rise to both CD103 + cDC subsets [12] . While these findings open up the intriguing possibility that there may be dedicated subsets of 'gut-homing' cDC progenitors, it is of note that these cells also gave rise to splenic cDCs (preferentially CD8α + cDCs) and, in contrast to pre-cDCs, they also maintained the potential to develop into plasmacytoid DCs [12] . of total CD103 + cDCs in the colon [13] . CD103 + CD11b − cDCs dominate over CD103 + CD11b + cDCs in GALT [11] , however,
− cDCs are present in normal numbers in the intestine of RORγt −/− mice suggesting that they do not require GALT for their final differentiation and development [5] . [14] . These findings are intriguing in view of the usual association of CCR2 with monocyte-derived MPs, and indicate the need for further studies of the progenitors of this subset of cDCs in the intestinal LP.
Transcriptional factor requirements for intestinal cDC subsets
It is now clear that the development of the intestinal CD103 + CD11b − and CD103 + CD11b + cDC subsets is dependent on distinct transcription factors. Peripheral tissue CD103 + CD11b − cDCs, including those located in the intestinal LP and PPs, are dependent on basic leucine zipper transcription factor ATF-like 3 (Batf3), inhibitor of DNA-binding 2 (Id2), and IFN-regulatory factor 8 (IRF8) [9, 11, [15] [16] [17] (Fig. 2 ). CD103 + CD11b
− cDCs therefore appear developmentally linked to IRF8/Batf3-dependent lymphoid tissue resident CD8α + cDCs [15, 18, 19] .
Supporting this idea, CD103 + CD11b − cDCs in LP express CD8α [5, 20] and other markers typical of CD8α + lymphoid cDCs, including the chemokine receptor XCR1 [21, 22] and the C-type lectin DNGR-1 [23] , and lack expression of DC inhibitory receptor 2 (DCIR2) [24] and signal regulatory protein (SIRP) α [5, 24] . Conversely CD103 + CD11b + intestinal cDCs develop independently of IRF8, Id2, and Batf3 [9, 16] , and recent data from us, and others, suggest they may be developmentally related to splenic CD11b + CD4 + DCs [24, 25] . Both these populations of DCs express high levels of SIRPα and DCIR2 [5, 24] , and lack expression of XCR1 [21, 22] . Two recent multiphoton microscopy studies used refined methods for identifying hematopoietic Ag sampling cells in the intestine [44, 45] . Both studies performed direct in vivo imaging of the intestine to help limit the potential artifacts that had been a concern in previous ex vivo approaches and CD11c +/yfp x CX3CR1 
Migration of SI cDCs to draining MLNs
After acquiring Ag, intestinal cDCs migrate to draining MLNs in a CCR7-dependent manner [48] [49] [50] [51] . In earlier studies we provided strong, although indirect evidence that MLN CD103 + cDCs derive from the intestinal LP [49, 52] . By ex vivo confocal imaging of intestinal lymphatics and sampling of intestinal draining lymph, we [43] at cross-presenting Ag to CD8 + T cells in vitro [5] . Despite these findings, the role that particular intestinal migratory cDC subsets play in priming naïve CD4 + and CD8 + T cells in MLN in vivo is currently unclear, but could potentially be explored utilizing mice whose DCs are deficient in the distinct transcription factors described above.
LP cDCs in the generation of gut-homing T cells
One of the characteristic features of the intestinal immune system is its anatomical compartmentalization, in which T and B cells primed in the GALT and MLNs are imprinted with the specific ability to return to the mucosa. In the case of the SI, this is dependent on the induction of the gut-homing molecules CCR9 and α4β7 on primed T cells, which are receptors for the chemokine CCL25 and the vascular adhesion molecule mucosal vascular addressin cell adhesion molecule 1 (MADCAM-1), respectively (for reviews see [61] [62] [63] ). Early studies by us and others demonstrated that small intestinal and MLN CD103 + cDCs display an enhanced ability to induce CCR9 and α4β7 on responding T cells in vitro, compared with DCs isolated from other tissues [49, 52, 64] . Subsequently, MLN CD103 + cDCs were shown to have an enhanced ability to generate the vitamin A metabolite, retinoic acid (RA) [52, 65, 66] , which is essential for gut-tropic T-cell generation in vitro and in vivo [65, 67] . Cerovic et al. [5] recently observed that all migratory cDC subsets including the small fraction of CD103 − cDCs in intestinal lymph metabolize vitamin A and induce gut-homing receptors on responding T cells in vitro, a finding that is consistent with the idea that migratory cDCs are imprinted with the ability to metabolize Vitamin A from signals they receive in the SI mucosa (for recent review see [68] ). In contrast to these in vitro studies, the role of SI DC-derived RA in the generation of gut-tropic T cells in vivo remains unclear. Thus, intestinal LP and MLN T cells from mice lacking Batf3-dependent CD103 + CD11b − MLN DCs have normal expression of CCR9 and α4β7 [16] , and we have recently shown that mice selectively lacking CD103 + CD11b + MLN DCs maintain their ability to induce gut-homing receptors on CD4 + T cells in vivo [24] . These latter studies suggest that RA derived from either subset is sufficient to drive gut-tropic T-cell generation in vivo, or that there are other non-DC derived sources of RA, such as from MLN stromal cells [69, 70] , that fulfill this function.
LP cDCs in Th cell differentiation
Inducible FoxP3 + Treg-cell generation
The MLN is a site that favors the differentiation of inducible FoxP3 + regulatory T (iTreg) cells [56, 71] to generate RA ( [56, 71] and reviewed in [73] [4, 24] , despite normal total CD4 + T-cell and Th1-cell numbers [24] . Moreover we found that adoptively transferred CD4 + T cells failed to differentiate into Th17 cells in the MLNs of these mice following immunization with Ag and LPS and αCD40, while Th1-cell differentiation was unaffected. Mechanistically, it appeared that the selective absence of migratory CD103 + CD11b + cDCs in the MLNs resulted in reduced levels of IL-6, and that this was critical for driving Th17 differentiation in this location [24] .
The in vivo signals that imprint DCs with the ability to generate effector T cells in the healthy intestine are unclear, although a role for pattern recognition receptors including toll-like receptors (TLRs) and MyD88 signaling has been suggested [82, 83] . Indeed ligands for several TLRs including TLR2, TLR5, and TLR9 induce IL-6 production by CD103 + CD11b + DCs in vitro and promote their ability to generate Th17-cell differentiation [5, 20, 24] . In this regard, it is interesting to note that CD103 + CD11b + cDCs and CD103 + CD11b − cDCs express a partially overlapping and partially distinct array of pattern recognition receptors [20, 81, 84, 85] , suggesting that they may respond differentially to microbial signals in the intestinal lumen.
Summary and concluding remarks
Intestinal DCs are a crucial link between the innate and adaptive immune responses and thus provide an attractive target for therapeutic manipulation of the intestinal immune response. Although similar levels of CD11c and MHCII expression by intestinal DCs and M s have impeded reliable characterization of DCs in the past, recent advances in phenotyping now allow these cells to be more precisely discriminated. As a result, it is now believed that there are at least three populations of bona fide DCs in the murine intestinal LP: two CD103-expressing cDC subsets, CD103 + CD11b + and CD103 + CD11b − cDCs, which derive from committed cDC precursors; and a more recently described CD103 − CD11b + population whose functions and origins remain to be characterized fully. The recent development of specific knock out mouse models with selective reduction in individual intestinal cDC populations has also allowed researchers to start addressing the functions of individual intestinal cDC subsets in the regulation of adaptive immune responses in vivo. Initial studies with these mice have demonstrated that the previous assertions that CD103 + cDCs were inherently tolerogenic are incorrect, and that, for example intestinal CD103 + CD11b + cDCs play an important role in driving Th17 differentiation in the MLNs [24] . It remains unclear if each cDC subset is hardwired to generate specific aspects of the T-cell pool in vivo, or if plasticity of the subsets can allow each to drive different forms of T-cell responses as required. If so, it seems likely that this plasticity will be determined by signals from the local environment. As well as identifying the factors involved, it will be important to determine at what stage they act in cDC development. For instance, do local signals act on newly arrived precursors and predetermine the functions of their progeny, or do mature cDCs adjust when they encounter different contexts in the tissues? Finally it is important to note that progress has also been made in identifying cDC subsets in the human intestinal LP. The majority of cDCs in the healthy SI also express CD103 and can be similarly divided into two subsets [24] , a major population of SIRPα + IRF4-expressing cDCs that we speculate are equivalent to murine intestinal CD103 + CD11b + DCs, and a minor population of CD141 + cDCs that are likely equivalents of CD103 + CD11b − DCs [86] [87] [88] . It remains to be seen if an equivalent to murine CD103 − cDCs exists in the human intestine. Determining whether these human intestinal cDC subsets function in a similar way to their murine counterparts will be important if these cells are to be exploited for the treatment and/or prevention of human inflammatory bowel diseases and in the development of mucosal vaccines.
